Indication
vaccination
4 clinical trials
3 products
Clinical trial
Influenza Immunization in Adults Over Age 75Status: Recruiting, Estimated PCD: 2025-03-01
Product
InfluenzaClinical trial
Comparison of the Immune Response After Administration of 2 vs. 3 Doses of the FDA-approved 9-Valent HPV Vaccine Among Women 27-45 Years of AgeStatus: Recruiting, Estimated PCD: 2026-08-01
Product
9-valent HPV vaccineClinical trial
A Pilot Study of the Immunogenicity of a Two-dose Protocol for 9-valent Human Papilloma Virus Vaccination in Postpartum Girls and Women (15-45 Years Old) Previously Unvaccinated Against HPVStatus: Completed, Estimated PCD: 2022-07-01
Product
Gardasil9Clinical trial
GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd DoseStatus: Active (not recruiting), Estimated PCD: 2025-03-01